Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients
NCT07039331 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2025-07-01
Summary
The primary endpoint of the study is the reduction of insulin levels between the two groups. Using the Student's t-test, while maintaining the study power at 95% and the significance level at 5%, a sample of 27+27 patients will allow the identification of differences in terms of Cohen's d equal to 1.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Short Term Fasting
Short Term Fasting during the first three cycles of NACT (36h before and 24h after the end of each cycle of CT).
- OTHER
-
Free Diet
Ordinary diet during the first three cycles of NACT without any change.
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Claudia Marchetti · Fondazione Policlinico Universitario A. Gemelli, IRCCS
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-07
- Primary Completion
- 2026-04-01
- Completion
- 2026-08-01
Countries
- Italy
Study Locations
More Related Trials
-
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
NCT07269574 ·Status: NOT_YET_RECRUITING
-
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer
NCT06216496 ·Status: RECRUITING ·Phase: NA
-
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
NCT05990426 ·Status: RECRUITING ·Phase: NA
-
The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
NCT06556342 ·Status: RECRUITING ·Phase: NA
-
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer
NCT02312661 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer
NCT01266954 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer
NCT05976932 ·Status: UNKNOWN
-
Tumor Gene Expression in Women With Ovarian Cancer
NCT00817479 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
NCT03858166 ·Status: TERMINATED ·Phase: PHASE4
-
Fermented Wheat Germ Extract in Women With Ovarian Cancer
NCT02411565 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
NCT05827523 ·Status: RECRUITING ·Phase: PHASE3
-
Assessment of Ovarian Reserve in Female Cancer Survivors
NCT01062542 ·Status: COMPLETED
-
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
NCT04169997 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ovarian Reserve Testing in Female Young Adult Cancer Survivors
NCT01421095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
NCT02475772 ·Status: COMPLETED ·Phase: PHASE1
-
Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation
NCT05763472 ·Status: UNKNOWN
-
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
NCT06468254 ·Status: RECRUITING ·Phase: PHASE2
-
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
NCT01492920 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3
-
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02122185 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Letrozole in Recurrent Ovarian Cancer
NCT04421547 ·Status: TERMINATED ·Phase: PHASE3